King Luther Capital Management Corp Grows Position in HealthEquity, Inc. (NASDAQ:HQY)

King Luther Capital Management Corp grew its stake in HealthEquity, Inc. (NASDAQ:HQY) by 9.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 50,190 shares of the company’s stock after purchasing an additional 4,343 shares during the period. King Luther Capital Management Corp owned about 0.06% of HealthEquity worth $4,816,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the stock. Assetmark Inc. raised its stake in shares of HealthEquity by 457.5% during the 3rd quarter. Assetmark Inc. now owns 4,544 shares of the company’s stock worth $372,000 after buying an additional 3,729 shares during the period. GSA Capital Partners LLP acquired a new position in shares of HealthEquity during the 3rd quarter worth approximately $638,000. Oppenheimer Asset Management Inc. raised its stake in shares of HealthEquity by 7.7% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 69,139 shares of the company’s stock worth $5,659,000 after buying an additional 4,925 shares during the period. KBC Group NV raised its stake in shares of HealthEquity by 16.1% during the 3rd quarter. KBC Group NV now owns 2,463 shares of the company’s stock worth $202,000 after buying an additional 341 shares during the period. Finally, Zions Bancorporation N.A. raised its stake in shares of HealthEquity by 15.8% during the 3rd quarter. Zions Bancorporation N.A. now owns 20,608 shares of the company’s stock worth $1,687,000 after buying an additional 2,816 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

HQY has been the subject of several research analyst reports. BTIG Research upped their target price on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research note on Thursday, November 14th. JMP Securities upped their target price on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research note on Tuesday, December 10th. The Goldman Sachs Group started coverage on HealthEquity in a research note on Friday, November 15th. They set a “neutral” rating and a $108.00 target price for the company. Raymond James increased their price objective on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Tuesday, February 25th. Finally, Mizuho started coverage on HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price objective for the company. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $113.54.

HealthEquity Stock Up 0.0 %

Shares of HQY opened at $95.78 on Thursday. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59. The company has a market capitalization of $8.30 billion, a PE ratio of 87.87, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. The stock has a fifty day simple moving average of $105.75 and a two-hundred day simple moving average of $94.93. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period last year, the company earned $0.40 earnings per share. As a group, equities analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current year.

Insiders Place Their Bets

In other news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares in the company, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 2.20% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.